Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Intellipharmaceutics International Inc
IPCIQ
Healthcare
Biotechnology
Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this...
technology platform, it has developed various drug delivery systems and a pipeline of products, and product candidates in various stages of development, in therapeutic areas that include neurology and cardiovascular. Its pipeline of products includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR, Generic Pristiq and Generic Ranexa. Its generic product candidates also include Trazodone hydrochloride extended-release tablets and Carvedilol phosphate extended-release capsules.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IPCIQ)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
Next
(14)
•••
quark_1
X
View Profile
View Bullboard History
Comment by
quark_1
on May 26, 2019 4:25pm
RE:FDA APRROVED OXY big news market missing it
(63)
•••
Dollarpee
X
View Profile
View Bullboard History
Post by
Dollarpee
on May 12, 2019 6:30pm
$268M in Sales + FDA Approval = $1++
Dr. Isa Odidi, CEO of Intellipharmaceutics, stated, "We have achieved yet another milestone and believe that this approval demonstrates the Company's ability to successfully take product
...more
(82)
•••
ROUGETRADER719
X
View Profile
View Bullboard History
Post by
ROUGETRADER719
on May 10, 2019 2:18pm
FDA APRROVED OXY big news market missing it
this going to over buck shortly imo
(32)
•••
AstonMartin13
X
View Profile
View Bullboard History
Comment by
AstonMartin13
on May 08, 2019 10:10pm
RE:RE:RE:RE:RE:RE:RE:Reverse split
Because of the new financing deal. But i am loading up for August!
(189)
•••
biggerr
X
View Profile
View Bullboard History
Comment by
biggerr
on May 07, 2019 9:01pm
RE:RE:RE:RE:RE:RE:Reverse split
why did it hit 32 cents in the morning, if somebody is willing to pay so much maybe some news are leakiing
(189)
•••
biggerr
X
View Profile
View Bullboard History
Comment by
biggerr
on Apr 29, 2019 3:02pm
RE:RE:RE:RE:RE:Reverse split
this patent fight with Purdue reminds me of the BB's patent fight in the early 2000s with another company which BB eventually won, leading its stock to multiply only to be destroyed later by Apple
...more
(189)
•••
biggerr
X
View Profile
View Bullboard History
Comment by
biggerr
on Apr 24, 2019 3:58pm
RE:RE:RE:RE:Reverse split
the only valuable asset IPCI has is this Oxy anti-abuse drug, everything else is garbage. It's the only junior with the PDUFA date that I know of, anybody knows any others?
(189)
•••
biggerr
X
View Profile
View Bullboard History
Comment by
biggerr
on Apr 17, 2019 12:36pm
RE:RE:RE:Reverse split
I'm holding out for the PDUFA in August, could be a multibagger if approved which is almost guaranteed, IMHO of course
(189)
•••
biggerr
X
View Profile
View Bullboard History
Comment by
biggerr
on Apr 17, 2019 12:00am
RE:RE:Reverse split
the only reason to hold IPCI is the Oxy anti-abuse pill and maybe potentially some CBD drugs
(49)
•••
nemo3
X
View Profile
View Bullboard History
Comment by
nemo3
on Apr 12, 2019 1:30pm
RE:Reverse split
yes
(42)
•••
Malfuncion
X
View Profile
View Bullboard History
Post by
Malfuncion
on Apr 12, 2019 1:25pm
Reverse split
Has this been done already
(189)
•••
biggerr
X
View Profile
View Bullboard History
Comment by
biggerr
on Apr 11, 2019 3:04pm
RE:loaded up for August.
when FDA gives you the PDUFA date that's pretty much like it's approved and the cap is only $9 mil., we talking about sales in $ hundreds of millions
(32)
•••
AstonMartin13
X
View Profile
View Bullboard History
Post by
AstonMartin13
on Apr 11, 2019 11:41am
loaded up for August.
if drops il buy more.
(189)
•••
biggerr
X
View Profile
View Bullboard History
Comment by
biggerr
on Apr 10, 2019 4:37pm
RE:RE:it's a buy today for me
drug abuse prevention is a billion dollar market in the US, it doesn't look like the drug will be rejected again. Lightning doesn't strike twice
(13)
•••
Mexymax
X
View Profile
View Bullboard History
Comment by
Mexymax
on Apr 05, 2019 12:56pm
RE:it's a buy today for me
Yep, the land of the brave and the home of the free continues to be a shining beacon in ....... almost nothing!
Prev
1
2
3
4
5
6
7
8
9
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
LEARN about a Biotech Rising to New Heights and Transforming Regenerative Medicine